Maravai LifeSciences
MRVI
#5427
Rank
โ‚น119.23 B
Marketcap
โ‚น325.42
Share price
-2.43%
Change (1 day)
-29.22%
Change (1 year)

Revenue for Maravai LifeSciences (MRVI)

Revenue in 2025 (TTM): โ‚น16.60 Billion

According to Maravai LifeSciences 's latest financial reports the company's current revenue (TTM ) is โ‚น17.33 Billion. In 2024 the company made a revenue of โ‚น22.22 Billion a decrease over the revenue in the year 2023 that were of โ‚น24.05 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Maravai LifeSciences from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น16.60 B-25.28%
2024 โ‚น22.22 B-7.62%
2023 โ‚น24.05 B-67.08%
2022 โ‚น73.06 B22.83%
2021 โ‚น59.48 B186.32%
2020 โ‚น20.77 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
โ‚น57.89 B 234.02% Jersey
Novavax
NVAX
โ‚น92.33 B 432.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
โ‚น12.98 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
โ‚น1.96 B-88.64%๐Ÿ‡ฌ๐Ÿ‡ง UK